GENOCEA BIOSCIENCES INC - COM NEW (GNCA)

CUSIP: 372427401

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM NEW
Total 13F shares
31,799,189
Share change
+2,417,933
Total reported value
$76,949,520
Put/Call ratio
20%
Price per share
$2.42
Number of holders
37
Value change
+$5,912,477
Number of buys
19
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 372427401?
CUSIP 372427401 identifies GNCA - GENOCEA BIOSCIENCES INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GENOCEA BIOSCIENCES INC - COM NEW (GNCA) as of Q4 2020

As of 31 Dec 2020, GENOCEA BIOSCIENCES INC - COM NEW (GNCA) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,799,189 shares. The largest 10 holders included NEA Management Company, LLC, Avoro Capital Advisors LLC, BVF INC/IL, KINGDON CAPITAL MANAGEMENT, L.L.C., CITADEL ADVISORS LLC, COMMODORE CAPITAL LP, VANGUARD GROUP INC, BOXER CAPITAL, LLC, BANK OF AMERICA CORP /DE/, and RENAISSANCE TECHNOLOGIES LLC. This page lists 37 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.